FDA.reportPublic FDA data

HYPROMELLOSE 2208 (100000 MPA.S)

Substance profile for UNII VM7F0B23ZI, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
VM7F0B23ZI
Preferred term
HYPROMELLOSE 2208 (100000 MPA.S)
Registry number
9004-65-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1300448
PubChem
0
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1300448https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1300448
FDA Substance Registration SystemVM7F0B23ZIhttps://precision.fda.gov/uniisearch/srs/unii/VM7F0B23ZI

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIDrug Facts1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITheophylline Extended-Release Tablets1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZISenophylline8
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1001
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIJANUMET XR (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [MERCK SHARP & DOHME CORP.]16
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIKHEDEZLA EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [PERNIX THERAPEUTICS]14
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIDEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE (DEXTROAMPHETAMINE SULFATE) CAPSULE, EXTENDED RELEASE [MALLINCKRODT, INC.]11
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIKHEDEZLA EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [PAR PHARMACEUTICAL INC.]10
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIOXYMORPHONE HYDROCHLORIDE EXTENDED-RELEASE (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [MALLINCKRODT, INC.]9
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIDESVENLAFAXINE EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [MACOVEN PHARMACEUTICALS]7
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIDUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]7
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIMEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC]7
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIMEDI-DERM RX (METHYL SALICYLATE, MENTHOL AND CAPSAICIN) CREAM [TWO HIP CONSULTING, LLC]6
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIDOLORACIN/L RX WITH LIDOCAINE (METHYL SALICYLATE, MENTHOL, CAPSAICIN AND LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC]5
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [PLIVA INC.]5
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIMEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC]4
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIMETFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AUROBINDO PHARMA LIMITED]4
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIMETFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC]4
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIDOLORACIN RX (METHYL SALICYLATE, MENTHOL AND CAPSAICIN) CREAM [TWO HIP CONSULTING, LLC]3
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIMEDI-DERM / L WITH LIDOCAINE (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC]3
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [CARDINAL HEALTH]3
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITOPICAL PAIN RELIEF (METHYL SALICYLATE, MENTHOL, CAPSAICIN) CREAM [UNIT DOSE SERVICES]3
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIDUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS]2
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]2
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITOPICAL PAIN RELIEF (METHYL SALICYLATE, MENTHOL, CAPSAICIN) CREAM [TWO HIP CONSULTING, LLC]2
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITOPICAL PAIN RELIEF RX (METHYL SALICYLATE MENTHOL CAPSAICIN) CREAM [TWO HIP CONSULTING, LLC]2
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIDUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIMEDI-DERM TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN) CREAM [TWO HIP CONSULTING, LLC]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIMETFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [CLINICAL SOLUTIONS WHOLESALE]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE (THEOPHYLLINE) TABLET, EXTENDED RELEASE [AVKARE, INC.]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS LLC]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [CLINICAL SOLUTIONS WHOLESALE]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [MAJOR PHARMACEUTICALS]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [PREFERRED PHARMACEUTICALS, INC.]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [REMEDYREPACK INC. ]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIXIGDUO XR (DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [ASTRAZENECA PHARMACEUTICALS LP]1